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Patel BV, Tatham KC, Wilson MR, O’Dea KP, Takata M. In
vivo compartmental analysis of leukocytes in mouse lungs. Am J
Physiol Lung Cell Mol Physiol 309: L639–L652, 2015. First pub-
lished August 7, 2015; doi:10.1152/ajplung.00140.2015.—The lung
has a unique structure consisting of three functionally different com-
partments (alveolar, interstitial, and vascular) situated in an extreme
proximity. Current methods to localize lung leukocytes using bron-
choalveolar lavage and/or lung perfusion have significant limitations
for determination of location and phenotype of leukocytes. Here we
present a novel method using in vivo antibody labeling to enable
accurate compartmental localization/quantification and phenotyping
of mouse lung leukocytes. Anesthetized C57BL/6 mice received
combined in vivo intravenous and intratracheal labeling with fluoro-
phore-conjugated anti-CD45 antibodies, and lung single-cell suspen-
sions were analyzed by flow cytometry. The combined in vivo
intravenous and intratracheal CD45 labeling enabled robust separation
of the alveolar, interstitial, and vascular compartments of the lung. In
naive mice, the alveolar compartment consisted predominantly of
resident alveolar macrophages. The interstitial compartment, gated by
events negative for both intratracheal and intravenous CD45 staining,
showed two conventional dendritic cell populations, as well as a
Ly6Clo monocyte population. Expression levels of MHCII on these
interstitial monocytes were much higher than on the vascular Ly6Clo
monocyte populations. In mice exposed to acid aspiration-induced
lung injury, this protocol also clearly distinguished the three lung
compartments showing the dynamic trafficking of neutrophils and
exudative monocytes across the lung compartments during inflamma-
tion and resolution. This simple in vivo dual-labeling technique
substantially increases the accuracy and depth of lung flow cytometric
analysis, facilitates a more comprehensive examination of lung leu-
kocyte pools, and enables the investigation of previously poorly
defined “interstitial” leukocyte populations during models of inflam-
matory lung diseases.
alveolus; lung interstitium; pulmonary capillary vasculature; flow
cytometry; leukocyte trafficking
RESIDENT ALVEOLAR AND INTERSTITIAL leukocytes (6, 43) as well
as infiltrating blood-derived leukocytes (3, 37, 47) play pivotal
roles in the lung during health and disease. However, current
experimental techniques in animal models do not allow dis-
crimination between the precise locations of these cells across
different lung compartments, thereby significantly limiting our
understanding of pathophysiology. For instance, blood leuko-
cytes start to play fundamental roles in the evolution of
inflammatory lung diseases when they are marginated/se-
questered within the lung microvasculature (6, 26, 47) and
subsequently show distinct intercellular interactions during
transendothelial and transepithelial migration (15, 25, 38,
59). Because the majority of investigations do not separate
alveolar, interstitial, vascular-marginated, and blood leuko-
cyte populations, precise phenotype changes and functions
of leukocytes as they migrate through each of the different
lung compartments remain unknown.
Many investigations assume that lavage of the alveolar space
or flushing of the pulmonary vasculature removes almost all
alveolar and vascular cells, respectively. However, this is
indeed not the case. Considerable portions of resident alveolar
macrophages still remain within the lung even with multiple
aggressive lung lavages using EDTA (5, 14). Similarly, flushing
the vasculature of the lung was found to leave behind a substan-
tive number of cells that are marginated and still attached to the
endothelium (2, 56), making the differentiation between lung
interstitial and intravascular spaces very difficult. In addition,
vigorous lung perfusion has been shown to have a negative impact
on the preservation of lung architecture (2). Hence, these proto-
cols do not allow a reliable and accurate assessment of cell
localization and number. More recently, imaging techniques such
as intravital microscopy have been utilized to investigate intersti-
tial leukocytes, but these techniques only allow the labeling of two
or three cellular epitopes, limiting the examination of complex
cellular phenotypes (8, 26). Furthermore, their application is
limited to the subpleural areas, which may not be representative of
the whole lung (8, 27, 52). Morphometric analysis (e.g., light and
electron microscopy) remains subjective, semiquantitative, and
time consuming.
The aim of this study is to develop and validate an in vivo
antibody labeling methodology to enable the flow cytomet-
ric separation of leukocyte subsets into the various lung
compartments. A number of previous studies have utilized
intravenous staining protocols to define vascular vs. tissue
leukocyte population in various organs (2, 4, 47), but such
techniques do not allow clear identification of the interstitial
compartment within the lungs. Here we utilize, for the first
time, a simultaneous in vivo dual intratracheal and intrave-
nous administration of anti-leukocyte antibodies to posi-
tively discriminate the alveolar and vascular cells and
through negative gating define the interstitial compartment.
This protocol allows the identification, quantification, and
classification of leukocytes into three compartments of the
mouse lung, in particular the elusive lung interstitium. This
simple yet powerful experimental approach will provide
researchers the opportunity to further explore biological and
immunological mechanisms important not only in the di-
verse range of inflammatory lung diseases but also in the
maintenance of lung homeostasis during health.
MATERIALS AND METHODS
All protocols were approved by the Ethical Review Board of
Imperial College London and carried out under the authority of the
UK Home Office in accordance with the Animals (Scientific
Procedures) Act 1986, UK. Wild-type C57BL/6 mice (Charles
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River, Margate, UK) aged 10 –12 wk and weighing 25–30 g were
used for all experiments. We first developed the dual in vivo
labeling technique using uninjured mice and then tested whether
this method could be used to chase leukocyte trafficking across the
lung compartments in disease states by using mice exposed to
acid-induced lung injury.
In vivo antibody labeling. Animals were anesthetized by intra-
peritoneal injection of xylazine (8 mg/kg) and ketamine (80 mg/kg)
and underwent tracheostomy whilst spontaneously breathing on
inspired O2 fraction (FIO2) 1.0. The right external jugular vein was
cannulated and 2 g of a phycoerythrin (PE)-conjugated anti-
CD45 antibody (diluted in 100 l sterile PBS) was administered,
together with heparin (10 IU/g), for systemic anticoagulation.
After 5 min, allowing for the circulation of the antibody, animals
were exsanguinated. The thoracic cavity was exposed through a
midline sternotomy and the lungs were gently teased from their
pleural adhesions. Subsequently, 5-0 silk sutures were placed
carefully around the right and left main bronchi. One or both lungs
underwent instillation (through the tracheostomy) with 0.5 or 1 ml
sterile PBS, respectively, containing 2 g/ml of a PE-Cy7 anti-
CD45 antibody. Each suture was securely tied at the hilum to avoid
spillage of the intratracheal antibody, and lungs were removed
from the thoracic cavity. These ligated lungs were exposed to the
intratracheal antibody for 5 min, after which they underwent
processing for preparation of single-cell suspension.
Preparation of single-cell suspension. Lungs underwent mechani-
cal disruption by a GentleMacs tissue dissociator (Miltenyi Biotec) for
1 min in 2 ml of intracellular fixative (eBioscience). This technique
allows immediate fixation and dissociation, enabling the best stability
of epitopes (39, 43). The fixation reaction was stopped through the
addition of 20 ml of ice-cold flow cytometry wash buffer (FWB)-PBS
with 2% FCS, 0.1% sodium azide, and 5 mM EDTA. The suspension
was subsequently sieved through a 40-m nylon filter and washed
again with 20 ml ice-cold FWB. The lung cell suspension was
centrifuged at 4°C at 2,000 rpm. The cell pellet was resuspended in 1
ml of FWB and placed on ice.
In vitro antibody staining. This was performed by incubation of
lung single-cell suspension (or whole blood for reference of cell
identification) with fluorochrome-conjugated antibodies for 30 min in
the dark at room temperature. The following panel of antibodies for
myeloid cell markers was used: CD45 (30-F11; BioLegend); CD11c
(N418, eBioscience); CD11b (M1/70; BD Biosciences); F4/80 (CI:
A3-1; BioLegend); CD103 (2E7; BioLegend); MHCII (M5/114.15.2;
BioLegend); Ly6G (RB6-8C5; BioLegend); Ly6C (AL-21, Becton
Dickinson Biosciences). A CD4 antibody (GK1.5, BioLegend) was
used for T cell identification. After incubation 4 ml of FWB was
added to lung cell suspension or 4 ml BD LyseFix solution to whole
blood and samples were centrifuged at 2,000 rpm at 4°C for 5 min.
Cells were resuspended in FWB and analyzed with a seven-channel
CyAn ADP flow cytometer (Beckman Coulter). Prior to analysis the
addition of AccuCheck counting beads (Invitrogen) enabled cell
counts to be calculated. Data were analyzed with FlowJo software
(Treestar).
Isolated perfused lung. The efficacy of lung perfusion for the
recovery of vascular leukocytes was evaluated by using the mouse
isolated perfused lung (IPL) model previously established in our
laboratory (18, 40, 56). In brief, anesthetized animals were injected
with intravenous anti-CD45 antibody (with heparin to prevent in-
trapulmonary coagulation), exsanguinated, and placed on the IPL
apparatus (Isolated Perfused Lung Size 1 Type 839; Hugo-Sachs
Elektronik, March-Hugstetten, Germany). After tracheostomy and
thoracotomy, the pulmonary artery and left atrium were cannulated,
and lungs were ventilated (tidal volume 7 ml/kg, positive end-
expiratory pressure 5 cmH2O, respiratory rate 80/min, with 21% O2
and 5% CO2 in N2) and perfused by RPMI 1640 without phenol red
with 4% BSA in a nonrecirculating manner, at a rate of 25
ml·kg1·min1 with an left atrial pressure of 2.5 mmHg. Experiments
were terminated at 1, 15, or 60 min, washed-out cells during this
perfusion period were collected from the total IPL perfusate, and lung
single-cell suspensions were also prepared from the postperfusion
lungs. Both samples were analyzed by flow cytometry, and the
numbers of vascular neutrophils labeled with in vivo-administered
anti-CD45 antibody were quantified.
Acid-induced lung injury. The in vivo labeling procedure under-
went testing in our recently published mouse model of acid-
induced lung injury (44). In brief, anesthetized animals were
vertically suspended on a custom-made mount from their incisors
by using a 2-0 suture. A nonthermal light source was used to
transilluminate the trachea. Careful retraction of the tongue and
laryngoscopy with blunt curved forceps allowed a grade 1–2 view
of the vocal cords. A fine catheter was subsequently guided 1 cm
below the vocal cords and 75 l of an isoosmolar 0.1 M hydro-
chloric acid (pH 1.0) solution was instilled. Animals were left
suspended for 1 min and then placed in a custom-made mouse
high-dependency recovery area. During this recovery period they
were actively warmed and given humidified supplemental oxygen,
with FIO2 initially at 1.0 and then gradually reduced to 0.21 over 4
h. To ensure even distribution of the instillate, mice were rotated
every 5 min until spontaneously moving. After this recovery period
they were placed in isolated ventilated cages with air and free
access to food and water for up to 4 days.
Statistical analysis. Data are expressed as means  SD. The
model assumption of normality of residuals was assessed by QQ
plot and the Shapiro-Wilk test. Statistical analyses of data were
made by either a two-tailed Student t-test or one-way ANOVA
with Bonferroni tests for intracompartmental comparisons between
multiple time points (if parametric) and Mann-Whitney/Kruskal-
Wallis tests (if nonparametric). Analyses of normal distribution
were performed with SPSS version 20 (IBM) and statistical com-
parisons used GraphPad Prism (version 6.0f). A P value of less
than 0.05 was considered significant.
RESULTS
Validation of compartmental staining protocol. To investi-
gate the compartmental localization of leukocytes, lungs were
labeled “in vivo” through administration of an intravenous
(PE-conjugated) followed by intratracheal (PE-Cy7 conju-
gated) anti-CD45 antibody in a step-by-step fashion (Fig. 1).
Firstly, in the absence of intravenous and intratracheal labeling
of the lung, events (after exclusion of debris using low forward
scatter) of lung single-cell suspensions analyzed by flow cy-
tometry are all negative in the PE and PE-Cy7 channels (Fig.
1A). The in vivo intravenous administration of a PE-conjugated
anti-CD45 antibody produces a clearly separate population of
CD45-positive cells (Fig. 1B, R1), which we define as cells
within the “vascular” compartment, leaving a population of
unlabeled nonvascular events (Fig. 1B, R2). Subsequently, this
lung cell suspension (from animals given intravenous PE-
conjugated CD45 antibody) was incubated in vitro with a
PE-Cy7-conjugated CD45 antibody (Fig. 1C). As expected, the
vascular population (R1) also stained positive for in vitro
CD45 (R3). This also led to a population of CD45-positive
cells (R4) emerging from the nonvascular gate (R2), leaving
behind an unstained nonleukocyte CD45 negative population
(R5). Finally, in vivo instillation (instead of in vitro incubation)
of the PE-Cy7 conjugated CD45 antibody into the airways,
following in vivo intravenous PE-conjugated antibody, stained
a population of cells positive for intratracheal CD45 and
negative for the intravenous CD45 (Fig. 1D, R6), which are
highly likely to be resident alveolar macrophages. The intra-
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vascular population remains clearly defined (Fig. 1D, R7). The
populations that are dual “negative” and not accessible to either
the intratracheal or intravenous administered CD45 antibodies
(Fig. 1D, R8) are likely to contain the interstitial leukocytes (as
well as all other lung parenchymal cells). Importantly, there
were virtually no dual-positive events (Fig. 1D, R9), suggest-
ing minimal bidirectional leak of in vivo antibody staining
between compartments. Importantly, the use of biexponential
scaling (22, 42) provides a clear and distinct separation be-
tween alveolar (R6), vascular (R7), and interstitial (R8) popu-
lations.
Distinguishing between lung alveolar and interstitial
compartments. Analysis of the alveolar (PE-Cy7 CD45pos)
compartment (i.e., intratracheal antibody positive and intrave-
nous antibody negative) revealed that a CD11cposCD11bneg
population accounted for over 95% of total alveolar events
(Fig. 2B, gate A1). This population was also highly autofluo-
rescent, MHCIIneg and CD103neg,and F4/80pos and SiglecFpos,
identifying them as resident alveolar macrophages, consistent
with previous literature (6, 23, 32, 33). The remaining 5%
of leukocytes within the alveolar compartment consisted
of CD11cposCD11bnegMHCIIposCD103pos (2%) and
CD11cposCD11bposMHCIIposCD103neg (2%) cells, which are
likely to be dendritic cell populations as described below, and
CD11bposLy6Gpos neutrophils (1%).
Within the interstitial compartment (i.e., double negative
for intratracheal PE-Cy7 and intravenous PE antibodies),
there were two CD11cpos leukocyte populations that can be
clearly distinguished by CD11b expression (Fig. 2C, B1 and
B2). These are both conventional dendritic cell (DC; cDC)
populations since they have very high expression of MHCII.
The two cDC populations can be further characterized by
differences in CD103 expression and this has previously
been shown to determine their specific location within the
lung, intraepithelial vs. lamina propria (28, 55). Population
B1 is CD11bnegCD103pos (intraepithelial cDC) whereas pop-
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Fig. 1. A: absence of antibodies shows a clear negative
population of cells when lung single-cell suspension is
analyzed with the phycoerythrin (PE) (x-axis) and PE-Cy7
(y-axis) channels. B: the in vivo intravenous (IV) injection
of a PE-conjugated CD45 antibody leads to a clear shift
rightward of an intravascular population (R1), leaving a
nonvascular region (R2). C: subsequent labeling of whole
lung single-cell suspension in vitro with a PE-Cy7 conju-
gated CD45 antibody leads to an upward shift of all
leukocyte populations. Of note, all intravenously CD45-
labeled leukocytes also stain positive for exogenous CD45
antibody (R3). Additionally, a population of cells emerges
from the intravascular CD45-negative group that also
express CD45 (R4). These are likely to be lung alveolar
and interstitial leukocyte populations. D: when the same
PE-Cy7-conjugated CD45 antibody is instilled intratrache-
ally (IT), 1 population is labeled strongly positive (R6)
and is likely to contain alveolar macrophages. The vascu-
lar compartment (R7) remains negative for the intratra-
cheal antibody. The events that are dual negative for both
intravenous and intratracheal CD45 antibodies is likely to
contain interstitial leukocyte populations (R8). The num-
ber of events found in R9, representing the extent of
bidirectional leak of antibody, is less than 0.5% of the total
population. This confirms that the in vivo labeling enables
separation of the alveolar, interstitial, and vascular com-
partments.
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ulation B2 is CD11bposCD103neg (lamina propria-located
cDC). Furthermore, in contrast to resident alveolar macro-
phages, these DC populations have low or negligible F4/80 and
SiglecF expression. The intraepithelial type cDC also shows
slightly greater CD86 expression. In summary, the intratra-
cheal labeling strategy enables us to clearly separate and
distinguish between “alveolar” resident macrophages and “in-
terstitial” resident dendritic cell populations. Table 1 describes
an overview of basic phenotypic characteristics of myeloid
cells within the three compartments of the mouse lung.
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Fig. 2. Distinguishing between the alveolar and interstitial compartments of the lung. A: in vivo labeling enables separation of the alveolar and vascular compartments
from the rest of the lung homogenate. The interstitial compartment is dual negative to both intravenous and intratracheal CD45 antibodies. B: gating on the alveolar
compartment shows that it predominantly contains a resident alveolar macrophage population (A1: red gate), which are relatively MHCIIneg, CD103neg, F4/80pos, and
SiglecFpos. C: the interstitial compartment [defined by those events not labeled by the intratracheal (PE-Cy7 CD45) and intravenous (PE CD45) antibodies] contains 2
populations of dendritic cells that are CD11cpos and MHCIIpos. One population is the intraepithelial-type conventional dendritic cells (cDC), CD11bnegCD103pos (B1:
blue gate), and the second is those cDCs resident in the lamina propria, CD11bposCD103neg (B2: green gate). D: the vascular compartment does not contain CD11cpos
events and only contains expected CD11bpos events, which are described in subsequent panels. E: relative expression of cell surface markers in resident alveolar
macrophages (red line); intraepithelial type cDC (blue line); and lamina propria-type cDC (green line) by compartmental analysis.
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Distinguishing between lung interstitial and vascular
compartments. The in vivo labeling technique showed that
virtually all CD11cnegCD11bpos events are situated within the
interstitial or vascular compartments, with minimal
CD11cnegCD11bpos events (1% of alveolar events) within the
alveolar space in healthy uninjured mouse lungs (Fig. 3A). The
CD11cnegCD11bpos leukocytes, within the interstitial compart-
ment (Fig. 3B), consisted of a predominant population of Ly6Clo
monocytes (CD11cnegCD11bposLy6GloLy6Clo cells, 95%; B2)
with the suggestion of a minor neutrophil presence
(CD11cnegCD11bposLy6GhiLy6Chi cells, less than 5%; B1). In
contrast, the vascular compartment (Fig. 3C) showed greater
proportion of neutrophils (C1; 35%) as well as a more varied
proportion of monocyte subsets: Ly6Clo (C3), 25%; Ly6Cinter
(C4), 10%; and Ly6Chi (C5), 25%. Given the limited number
of flow cytometry channels, a complete exclusion of NK cells
and eosinophils was not possible, but eosinophils (occupying
5% of events) are likely to be represented in gate C2
(CD11cnegCD11bposLy6GinterLy6Cinter cells) (48).
Finally, interstitial Ly6Clo monocyte populations were
found to have a significantly higher expression of MHCII
compared with their vascular Ly6Clo monocyte counterparts
(Fig. 3D). This clear separation in MHCII phenotype between
interstitial and vascular Ly6Clo monocytes confirms minimal
leak of intravenous antibody into the interstitial space in the
uninjured lung, further supporting the case that this in vivo
labeling protocol allowed robust differentiation between cells
within the vascular and interstitial compartments of the lung.
Compartmental analysis increases accuracy of anatomical
location. Current methods to analyze the anatomical location of
leukocytes rely on both lung lavage (to remove alveolar cells) and
pulmonary vascular perfusion (to remove vascular cells) with
subsequent analysis of the lung homogenate (for interstitial cells)
(5, 51). Thus a separate set of experiments was performed to
assess the efficacy of lung lavage for retrieval of alveolar macro-
phages (Fig. 4A). Uninjured mouse lungs underwent five repeti-
tive lavages via the endotracheal tube using one syringe contain-
ing 750 l normal saline. The recovered lavage fluid and lung
single-cell suspensions prepared from the remaining postlavage
lungs were analyzed by flow cytometry. The numbers of resident
alveolar macrophages (CD45posCD11cposCD11bnegF4/80pos)
were 4.5  2.4  104 in the recovered lavage fluid vs. 9.4 
1.5  105 in the lung homogenate. Hence, the overall retrieval
of resident alveolar macrophages by this standard lavage pro-
cedure was found to be only less than 5%.
In another series of experiments, the efficacy of lung vas-
cular perfusion for recovery of vascular leukocytes was eval-
uated by use of the IPL model. Mice underwent injection of
intravenous anti-CD45 antibody for in vivo labeling of vascu-
lar leukocytes and subsequently underwent lung perfusion for
1, 15, and 60 min. The numbers of intravenously labeled
CD45-positive neutrophils were counted in the washed-out cell
populations in the IPL perfusate as well as in the remaining
lung single-cell suspensions prepared from the postperfusion
lungs (Fig. 4B). The results showed that up to 50% of vascular
neutrophils labeled with the intravenous CD45 antibody still
remain within the lung tissue even after 60 min of lung
perfusion (Fig. 4B).
Application of compartmental analysis to experimental acid-
induced lung injury. Analyses of the flux of leukocytes through
the various compartments of lungs at various stages of lung
injury are crucial to gain better understanding into pathophys-
iology. The methods described above were applied to our
recently published acid aspiration model to gain a preliminary
insight into the effectiveness of the compartmental strategy
during injury. Animals underwent in vivo labeling at days 1, 2,
and 4 after acid aspiration, with day 0 representing uninjured
animals. These time points were predicted to best show influx
and efflux/loss of leukocytes during inflammation and its
resolution during lung injury (44). Figure 5 shows representa-
tive flow cytometry plots for the compartmental gating strategy
as discussed previously in the uninjured mouse. The propor-
tions of dual-positive events (Fig. 5), i.e., PEposPE-Cy7pos,
representing the extent of bidirectional leak of antibodies across
the alveolar capillary barrier, remains unchanged (at 0.5%)
between uninjured and injured animals even during significant
alveolar edema at days 1 and 2. Indeed, we have previously shown
that this acid-induced model produces a greater than 60% increase
in lung water content with significantly increased lavage protein
concentrations at days 1 and 2 (44). Hence, this protocol allows
consistent separation and gating of the three compartments in a
model with severe disruption of the alveolar-capillary barrier.
Figure 6 shows the CD11c and CD11b characteristics of leu-
kocytes after compartmental gating of the lungs as injury pro-
gresses. In the uninjured mouse lung, there are minimal numbers
of alveolar CD11bpos events and vascular CD11cpos events. The
alveolar compartment contains alveolar macrophages and some
DC populations with no monocytes and negligible numbers of
neutrophils. The interstitial compartment contains the two cDC
populations and the CD11cnegCD11bposLy6CloMHCIIpos subset
Table 1. Phenotypic characteristics of myeloid cell populations in the 3 compartments of the naive mouse lung
Cell Type CD11c CD11b MHCII CD103 F4/80 SiglecF Ly6C Ly6G CD86 AF
Alveolar compartment
Resident alveolar macrophage 			    			 			 			  	 			
Interstitial compartment
Intraepithelial cDC 			  			 			     		 
Lamina propria cDC 			 			 			  	    	 
Interstitial monocyte  		 			  	    			 
Vascular compartment
Classical 
inflammatory
 monocyte  		 	/  	  			  ? 
Nonclassical 
resident
 monocyte  		   	     
Eosinophil  		   	 ? 		 	 ? 			
Neutrophil  		     		 			 ? 	
	//, High/intermediate/low expression; , no expression; ?, not tested; AF, autofluorescence; cDC, conventional dendritic cell.
Innovative Methodology
L643COMPARTMENTAL ANALYSIS OF MOUSE LUNGS
AJP-Lung Cell Mol Physiol • doi:10.1152/ajplung.00140.2015 • www.ajplung.org
of interstitial monocytes (as in Fig. 2). Immediately after acid
aspiration, small numbers of CD11bpos events are seen to enter the
alveolar space as early as 3 h (not shown) and at day 1. However,
the predominant CD11bpos infiltration into the alveolar and inter-
stitial compartments occurs on day 2.
Figure 7 shows a more focused analysis of CD11bpos sub-
populations within each compartment with Ly6G and Ly6C
staining, while Fig. 8 shows a quantification of the dynamics of
neutrophil and monocyte influx and efflux within the alveolar
and interstitial lung compartments. There is an increase of
Ly6Gpos neutrophil populations at 24 h of acid-induced lung
injury in both alveolar and interstitial compartments. This
neutrophil infiltration peaks at day 2, and at the same time we
also see a large infiltration of CD11cnegCD11bposLy6Glo
monocyte-like cells, with a phenotype consistent with so-called
“monocyte-derived exudative macrophages” (19), which we
term “mono-mac” (Fig. 8, A and B). At day 2, this mono-mac
infiltrate consists initially of Ly6Cinter/hi populations within the
alveolar and interstitial spaces. In contrast, by day 4, the
Ly6Cinter/lo mono-mac events remain constant in number
whereas the alveolar and interstitial Ly6Chi populations dis-
appear. Of note, there are initial reductions in
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Fig. 3. Distinguishing between the interstitial and vascular compartments of the lung. A: there are no CD11cnegCD11bpos events in the alveolar space. B: the
interstitium contains a CD11cnegCD11bpos population that consists of some Ly6Ghi neutrophils (B1, 5%) but mainly Ly6Clo monocytes (B2, 95%). C: the
vascular space consists of a much larger population of CD11cnegCD11bpos events. These are separated into neutrophils (C1, 35%), eosinophils [also
Ly6GinterLy6Cinter (C2),5%], and monocytes [Ly6Clo (C3), 25%, Ly6Cinter (C4), 10%, and Ly6Chi (C5), 25%]. D: the interstitial Ly6Clo monocytes (B2, green
gate) have a significantly higher MHCII expression compared with the vascular Ly6Clo monocyte (V3, red gate) population. This supports our notion that the
compartmental strategy robustly distinguishes between interstitial and vascular compartments of the mouse lung. Data are means  SD with N  6; **P  0.01
vs. vascular subset.
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CD11cposCD11bnegF4/80pos alveolar macrophage populations
at 24 h (Fig. 8C). Interestingly, the number of these
CD11cposCD11bnegF4/80pos cells increases threefold (com-
pared with uninjured numbers) on day 2 during the insurgence
of these exudative mono-macs. As previously described, it is
from day 2 onward that injury resolves within this model (44),
and coincident with this are reductions in lung neutrophils
(likely through apoptosis).
To further characterize changes in leukocyte populations
within the alveolar and interstitial compartment during resolu-
tion, we focused on CD11bnegCD103pos dendritic and CD4pos
T cell populations (Fig. 9). As expected, in the uninjured lung
there are significant proportions of interstitial CD4pos T cells.
During acid-induced lung injury there were significant reduc-
tions in CD103pos dendritic cell populations from day 1 of
injury, which persisted throughout the injury period studied.
Additionally, there were significant increases in alveolar
CD4pos T cell populations on day 2 during mono-mac migra-
tion into the lung.
DISCUSSION
In this study we developed and validated a novel in vivo
labeling method that enables an in-depth analysis of leukocyte
location and phenotypes within the alveolar, interstitial, and
vascular compartments of the mouse lung by flow cytometry.
The protocols described here enable the positive identification
of leukocytes within the lung vascular and alveolar compart-
ments, and through a negative gating strategy the identification
of the interstitial compartment. Combining this in vivo labeling
strategy with in vitro use of a panel of multiple leukocyte
surface markers, we achieved robust differentiation and iden-
tification of various leukocyte populations across three lung
compartments in both the uninjured and injured mice. We
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showed that CD11c and CD11b are very useful global discrim-
inators of myeloid cell populations in various compartments of
the mouse lung. We confirmed clear separation between the
alveolar and interstitial compartments through establishing
distinct locations of resident alveolar macrophages
(CD11cposCD11bnegMHCIInegCD103neg F4/80posSiglecFpos
events) and two interstitial dendritic cells (CD11cposCD11bneg
MHCIIposCD103pos and CD11cposCD11bposMHCIIposCD103neg
events). An important distinction was found between the interstitial
and vascular CD11cnegCD11bposLy6GloLy6Clo monocyte popula-
tions, with the former showing significantly higher MHCII expres-
sion, similar to dendritic cells. On application to a clinically relevant
mouse model of lung injury with substantive alveolar-capillary dis-
ruption, we presented the validity of this protocol and described, for
the first time, the dynamics of leukocyte populations within the
various lung compartments during inflammatory and resolution
phases of acute lung injury.
Current methods for compartmental analyses of lungs
have critical limitations for determination of location and
phenotype of leukocytes. Despite recent advances in lung
biology research, there has been no study to accurately and
reliably address the precise numbers and phenotypes of
leukocytes within each lung compartment (5, 24, 33, 58),
mainly because of the unique morphology of the lung with
very thin alveolar-capillary structures, which significantly
limits the application of traditional histological techniques.
Alveolar 
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Fig. 6. Compartmental gating showing changes in CD11b and CD11c events during injury (between days 0 and 2) and resolution (between days 2 and 4) of acid
aspiration. There are increases in CD11b-positive events at day 2 within the alveolar and interstitial spaces. As injury progresses, resident CD11cposCD11bneg
alveolar macrophages in the alveolar compartment gain CD11b expression whereas recruited CD11cnegCD11bpos cells gain CD11c.
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In particular, investigation into the interstitial compartment
of the lung has long proven elusive. Johnston et al. (24)
performed cardiac perfusion and lavage procedures to de-
termine which cells were present within the lung intersti-
tium. However, we have demonstrated that standard lung
lavage does not retrieve the majority of cells from the
alveolar space. More aggressive lavage procedures (e.g.,
using EDTA) would damage the lung parenchyma, leading
to contamination of cells from the interstitial and vascular
spaces. Importantly, after the onset of lung injury the
recoverability of alveolar macrophages would substantively
worsen as a consequence of increased activation and adher-
ence, a concept called “the macrophage disappearance re-
action” (7, 20, 34). Our results have also shown that lung
perfusion does not remove all of neutrophils from the
pulmonary vasculature, consistent with our previous IPL
study on monocytes (56), and those marginated leukocytes
adhered relatively firmly to the lung endothelium would
play a substantial role in the pathophysiology of lung injury
(2, 39 – 41, 56, 57). In addition, lung perfusion following a
period of zero pulmonary flow (during surgical preparation)
may produce activation of endothelial cells (9, 10), stimu-
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Fig. 7. Changes to CD11bpos subpopulations within each compartment during acid-induced lung injury. The alveolar and interstitial compartments show an
increase in Ly6Ghi neutrophils on day 1 (red arrows) as well as the beginnings of an infiltration of Ly6Chi monocytes into the interstitial space (orange arrow).
This is followed by a marked increase in Ly6Chi/inter monocyte-derived exudative macrophages populations within the interstitial and alveolar compartment on
day 2 (green arrow). This population changes to a Ly6Clo/inter phenotype on day 4 (blue arrow). There are associated reductions in neutrophils within the alveolar
and interstitial space consistent with the resolution phase of lung injury. The vascular compartment shows a reduction in monocyte numbers on day 1, which
normalizes on day 4.
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lating production of reactive oxygen species (50) and pro-
moting neutrophil adherence/recruitment to the lung (36),
which may further reduce the recovery of vascular leuko-
cytes.
Recent studies have also provided panels of markers to
distinguish between various myeloid cells within the lung (1, 5,
24, 33, 58). However, such panels do not distinguish the
anatomical localization of leukocytes and do not account for
the potential changes in phenotypic markers during various
stages of lung injury. In particular, macrophages show signif-
icant plasticity in their cell surface markers during injury and
resolution (1). Our in vivo labeling method should supplement
these myeloid marker panels but, importantly, is not restrictive
to myeloid cells and has the added benefit to also enable the
localization of other immune cells, e.g., T cells. Indeed, it is
also feasible to perform in vivo labeling with alternative
antibodies, or antibody cocktails.
Bedoret et al. (6) characterized resident alveolar macro-
phages, interstitial macrophages, and dendritic cells using
immunohistochemistry and extensive lung lavage and
showed that alveolar macrophages were CD11cposF4/
80posMHCIIneg, interstitial dendritic cells were CD11cposF4/
80negMHCIIpos, and interstitial macrophages were
CD11cnegF4/80posMHCIIpos. The nomenclature of mono-
cytes vs. macrophages remains very confusing within the
literature. In contrast to the article by Bedoret, here we have
defined mature macrophages as those cells that exhibit clear
CD11c expression within the tissues. Such blood-borne
Ly6Chi monocyte-derived cells can differentiate either into
macrophages (or mono-mac) or dendritic cells (mono-DC)
(54, 60). Interestingly, we have found that these resident
interstitial monocytes, unlike vascular monocytes, show a
significant increase in CD86 expression within a model of
lung ischemia-reperfusion (unpublished results). Taken to-
gether with the high expression of MHCII, this suggests a
potential important immune modulatory role for these pre-
viously “invisible” cells, in particular, a link to adaptive T
cell responses.
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Fig. 8. A: neutrophil numbers significantly increase on day 2
after acid aspiration. Nearly 50% of all neutrophils are found
within the interstitial space at this time point. Interstitial neu-
trophils may have been newly recruited. B: there is also a
significant increase in monocyte migration into the interstitial
and alveolar spaces on day 2. On day 4, whereas the numbers
of Ly6Clo/inter monocytes are maintained within the compart-
ments, the numbers of Ly6Chi monocytes reduce significantly
in the alveolar compartment. C: there is a nonsignificant reduc-
tion in resident alveolar macrophage (CD11cposCD11bnegF4/
80pos) numbers on day 1 of injury followed by a 3-fold
increase in cells (on day 2) that have adopted a similar pheno-
type to resident alveolar macrophages. The replenishment of
CD11cposCD11bnegF4/80pos cells coincides with the infiltration
of exudative monocytes on day 2. The vascular space data have
been omitted because this may be subject to variability as a
result of differences in exsanguination between each animal.
Data are means  SD with N  3–5/time point; day 2 vs. day
0: *P  0.05 **P  0.01; day 4 vs. day 2: #P  0.05 (analysis
performed within compartments).
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It is important to consider the potential confounding factors
that would impede the ideal separation of lung compartments
in our methodology. The use of negative selection would
theoretically more or less “overestimate” the interstitial com-
partment as 100% labeling by intratracheal and intravascular
antibody, which would not be possible, e.g., owing to some
nonperfused/occluded vessels in the pulmonary vasculature.
However, Reutershan et al. (47) intravenously administered a
monoclonal antibody (against TER-119 on erythrocytes) and
showed near total labeling of all erythrocytes in the pulmonary
microvasculature of C57BL/6 mice. Similarly, our intratra-
cheal antibody showed labeling of over 98% of resident alve-
olar macrophages within the alveolar space with less than 2%
unstained.
On the other hand, if intravenous or intratracheal antibodies
inadvertently label cells in other compartments either in vivo or
during sample processing, e.g., unbound excess antibodies left
within the lung samples bind to cells in other compartments, it
would “underestimate” the interstitial compartment. However,
such “leaks” of in vivo administered antibodies to other lung
compartments appeared minimal in this study, because double-
positive events for intratracheal and intravascular antibodies
(expected to occur if significant bidirectional leaks take place)
were always less than 0.5% of total events, and this proportion
remained unchanged even in acid-injured mice with significant
alveolar-capillary barrier disruption. Furthermore, the majority
of these double-positive events were secondary to autofluores-
cence of resident alveolar macrophages.
Several precautions incorporated into our in vivo labeling
protocol may have helped to minimize such leak. Firstly,
intravenous CD45 antibody was injected and allowed to circu-
late for only 5 min. In our previous study using the same acid
model, when fluorescence-labeled albumin (with a molecular
weight of 66.5 kDa, compared with 160 kDa for anti-CD45
IgG) was injected intravenously to measure permeability in-
dex, we found that at least 30 min is required to detect
measurable amounts of albumin in lung lavage fluid (43). Thus,
within the time frame used in this study, it is unlikely that
sufficient amounts of intravenous antibody are translocated
into other lung compartments despite a substantively disrupted
alveolar capillary barrier. Secondly, mice were exsanguinated
(bled from inferior vena cava under systemic anticoagulation)
and their lungs were inflated for 5 min with a positive alveolar
pressure (with the intratracheal anti-CD45 antibody solution),
which enables maximal drainage of pulmonary blood (and
excess intravenous antibody). Further removal of excess intra-
vascular antibody can be obtained by flushing the pulmonary
vasculature, although this was not performed in this study to
maintain lung architecture as intact as possible. Thirdly, to
minimize the binding of any remaining unbound intratracheal
antibody (left within the alveoli and bronchial tree), steps were
implemented, including homogenization of the lung in the
largest possible fluid volume followed by immediate dilution
into 20 ml of ice-cold flow cytometry wash buffer. Drainage of
excess antibody out of the tracheobronchial tree was not
performed, given the potential for significant loss of cells from
the alveolar compartment. An alternative method would be to
homogenize the lung in excess nonconjugated anti-CD45 an-
tibody to saturate the CD45 epitope, preventing further conju-
gated antibody binding.
The compartmental analysis enables a simple yet dynamic
insight into the kinetics of leukocyte migration within the lung
during inflammatory pathology. Acid-induced lung injury in-
duced gradual increases in CD11b-positive events mainly on
day 2, consistent with our previous work (44). In addition to
neutrophils, we found a dual neutrophil and monocyte recruit-
ment into the lung interstitium at this time point, as has been
suggested in an endotoxin model of lung injury (17). There are
also significant increases in Ly6chi monocytes within blood at
this stage (data not shown) coinciding with their substantial
increase in the interstitial and alveolar compartments. Interest-
ingly, on day 4, this infiltrating Ly6chi monocyte population
adopts a Ly6clo phenotype within the interstitium whereas it
adopts a Ly6cinter phenotype within the alveolar space. Hence,
these data are consistent with the notion that exudative Ly6chi
mono-macs could serve to replenish resident populations (den-
dritic cells and resident alveolar macrophages are, respectively,
Ly6clo and Ly6cinter) within the lung after injury (29, 32). This
is also suggested by the increase in numbers of resident
alveolar macrophages on day 2 after their initial reduction on
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day 1. Landsman et al. (29) showed that Ly6chi monocytes
could give rise to alveolar macrophages after having adopted a
Ly6clo phenotype, potentially explaining the sustained alveolar
presence of Ly6clo monocytes.
Janssen et al. (23) compared dynamics of resident and
recruited macrophages in model of endotoxin-induced lung
injury. To place this into context with our study, which shows
an increase in the CD45posCD11cposCD11bnegF4/80pos alveolar
macrophage pool, the Janssen study also showed a small
increase in resident alveolar macrophages after a dramatic
increase in recruited macrophages. However, their study only
analyzed cells within bronchoalveolar lavage and, therefore,
should have substantially underestimated the precise numbers
of resident and recruited macrophages within the alveolar
compartment. Furthermore, it is important to consider the
relative efficacies of retrieval by lung lavage between various
immune cell types (e.g., resident vs. monocyte-derived exuda-
tive macrophages; newly recruited vs. apoptotic exudative
macrophages) and between various phases of injury (e.g.,
inflammatory vs. resolving phases). Our protocol of in vivo
labeling removes many of these potential sources of error
intrinsic to methods reliant on lung lavage.
On day 4, our data show reductions in Ly6chi monocytes
with concomitant increases in Ly6clo/inter monocytes, consis-
tent with evidence in other models of inflammatory resolution
of a phenotypic switch from Ly6Chi to Ly6Clo (11, 46). During
sterile injury, this switch from inflammatory Ly6Chi to resolv-
ing Ly6Clo mono-mac phenotypes would imply an increased
phagocytosis potential and hence could explain the reductions
in neutrophils (through apoptosis and efferocytosis) within the
alveolar space (11). Plantinga et al. (45) showed that mono-
cytes rapidly downregulate Ly6C on differentiation to mono-
DCs within the lung and suggest this to be a highly specific
effector of T cell responses. Simultaneously with this transition
in mono-mac Ly6C phenotype, we also found increases in
CD4pos T cells within the interstitium at day 2. Furthermore,
circulating Ly6Chi monocytes have been shown to differentiate
into fibrocytes under the influence of CD4pos T cells (35), and
Ly6chi monocytes have been implicated in driving fibrosis
within a bleomycin-induced lung injury model (21). Interest-
ingly, our model of acid aspiration produces significant fibrosis
and collagen deposition from day 2 (44). Whether the highly
immunomodulatory subset of T cells (CD4posCD25posFoxP3pos)
affects such changes in mono-mac Ly6C phenotype and ulti-
mately resolution of inflammation (12, 13) has yet to be deter-
mined.
The complex interactions between innate and adaptive im-
mune responses facilitated by dendritic cells have been of
considerable interest in numerous mucosal surfaces including
the gut and skin (30, 54). Indeed, CD11bnegCD103pos intraepi-
thelial cDCs bind to epithelial cells using the E7 integrin
CD103, the only known ligand for the epithelial integrin
E-cadherin (31, 53). Their early loss during acid-induced lung
injury may reflect the significant epithelial injury induced
within this model (44). Indeed, these CD103pos cDCs have
been shown in the gut epithelium to initiate adaptive immune
responses in local lymph nodes (49) and within the lung to
transport apoptotic cell-associated antigens to draining lymph
nodes (16). A limitation of our study was the restriction to a
seven-channel flow cytometer, and only five channels after
dual intravenous and intratracheal labeling. Additional chan-
nels to differentiate CD11bposCD103neg dendritic cell popula-
tions from infiltrating CD11bpos mono-DCs by using antibod-
ies against CD68 or MAR-1 would have further increased the
depth of our analysis (45). More detailed compartmental anal-
ysis of the lungs could potentially yield invaluable insights into
the roles of such leukocyte interactions and transitions during
inflammation and its resolution.
In conclusion, we present an in vivo antibody-labeling
methodology to analyze the subsets of myeloid cells within the
three compartments of the lung. This protocol takes full ad-
vantage of the multiparameter analysis capabilities of flow
cytometry and enables robust discrimination of the location
and phenotype of leukocytes within healthy and injured mouse
lungs. Combining this protocol with more recent myeloid cell
panels and technologies such as conditional/inducible gene
modification would substantively facilitate investigations into
transcompartmental trafficking of leukocytes within the lungs.
We propose application of this simple in vivo lung compart-
mental analysis to other lung biology research to discover
novel insights into the roles of leukocytes within the lung.
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